Primary Objective:
- To assess the sexual function of Benign Prostatic Hyperplasia patients
Secondary Objective:
- To evaluate the association between Lower Urinary Tract Symptoms severity and sexual
disorders
- To compare the sexual function, urinary symptoms and Quality of Life of Benign Prostatic
Hyperplasia patients on XATRAL 10mg OD among the different regions
- To correlate the Male Sexual Health Questionnaire(MSHQ) and 5-item version of the
International Index of Erectile Function (IIEF-5)
- To assess the onset of action of XATRAL 10mg OD
- To assess the peak urinary flow rate
- To assess the safety and the tolerability of XATRAL 10mg OD